1162583000: Aducanumab (substance)

SNOMED CT Concept\Substance\...

\Drug or medicament (substance)\Monoclonal antibody\Aducanumab

\Substance categorised by structure\Chemical\Chemical categorized by structure\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody\Aducanumab

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody\Aducanumab

\Biological substance\Protein and/or protein derivative\Protein\Antibody\Monoclonal antibody\Aducanumab
\Biological substance\Immunologic substance\Antibody\Monoclonal antibody\Aducanumab
\Biological substance\Polypeptide\Protein\Antibody\Monoclonal antibody\Aducanumab

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

4590255017 Aducanumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

4590256016 Aducanumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

4590255017 Aducanumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

4590256016 Aducanumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Aducanumab	Is a	Monoclonal antibody	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Aducanumab-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Aducanumab	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Aducanumab only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Aducanumab	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Aducanumab-containing product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Aducanumab	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Aducanumab only product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Aducanumab	Inferred relationship	Existential restriction modifier (core metadata concept)	1

This concept is not in any reference sets